Fludarabine Terminated Phase 1 Trials for Stage II Multiple Myeloma / Refractory Multiple Myeloma / Stage I Multiple Myeloma / Stage III Multiple Myeloma Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01954784Lenalidomide After Donor Stem Cell Transplant and Bortezomib in Treating Patients With High Risk Multiple Myeloma